10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001213900-19-023219`
Period End Date	20190930
Filing Date	20191113
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	rlmd-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 20 Cash Flow Statement 45 Stockholders Equity 16

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	-	USD	Point-in-time
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$887.49K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.85M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$176.98K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - short-term	`LeaseIncentiveReceivableCurrent`	$70.10K	USD	Point-in-time
Lease payments receivable - short-term	`LeaseIncentiveReceivableCurrent`	$71.58K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$520.75K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$376.90K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.98M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.30M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.74M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.94M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$7.21K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$6.11K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.94M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.74M	shares	Point-in-time
Lease payments receivable - long-term	`LeaseIncentiveReceivableNoncurrent`	$184.68K	USD	Point-in-time
Lease payments receivable - long-term	`LeaseIncentiveReceivableNoncurrent`	$203.14K	USD	Point-in-time
Total assets	`Assets`	$10.22M	USD	Point-in-time
Total assets	`Assets`	$8.51M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$924.36K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.27M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.01M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.32M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$255.93K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$364.20K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.54M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.61M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 9,937,608 and 9,744,643 shares issued and outstanding, respectively	`CommonStockValue`	$9.94K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 9,937,608 and 9,744,643 shares issued and outstanding, respectively	`CommonStockValue`	$9.74K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$121.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$119.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-115.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-111.66M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$5.98M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-8.68M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$7.61M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$10.22M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$8.51M	USD	Point-in-time

Income Statement 20 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.42M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.89M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.82M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$989.75K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.71M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.41M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-318.54K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-650.32K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$37.92K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$37.92K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-968.86K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.38M	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.08	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.38	USD	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.76M	shares	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.14M	shares	1 Quarter

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.38M	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.41K	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.10K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$757.72K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$152.80K	USD	1 Quarter
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	$536.52K	USD	1 Quarter
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-318.54K	USD	1 Quarter
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-7.62K	USD	1 Quarter
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-176.98K	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	$-16.98K	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	$-15.62K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-143.84K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-115.98K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$342.19K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$253.92K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$306.71K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-303.46K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.67M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.53M	USD	1 Quarter
Principal payments of notes payable	`RepaymentsOfNotesPayable`	$108.28K	USD	1 Quarter
Principal payments of notes payable	`RepaymentsOfNotesPayable`	$84.97K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$825.75K	USD	1 Quarter
Warrants exercised for common stock	`ProceedsFromWarrantExercises`	$450.00K	USD	1 Quarter
Units funds received	`ProceedsFromIssuanceOrSaleOfEquity`	$404.50K	USD	1 Quarter
Units funds received	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.17M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$319.53K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.35M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.37M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$887.49K	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.85M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$887.49K	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.85M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Interest	`InterestPaidNet`	$2.54K	USD	1 Quarter
Interest	`InterestPaidNet`	$1.51K	USD	1 Quarter

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$5.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$-8.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time
Cumulative effect of Write-off of Derivative Liabilities under ASU 2017-11	`WriteoffOfSeriesDerivativeLiabilityForAdoptionValue`	$59.40K	USD	1 Quarter
Adjusted Balances as at July 1, 2018	`StockholdersEquityAdjustedBalances`	$-5.45M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$152.80K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$757.72K	USD	1 Quarter
Purchase of common stock	`StockIssuedDuringPeriodValueAcquisitions`	$825.75K	USD	1 Quarter
Warrants exercised	`WarrantExercisedValue`	$450.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.38M	USD	1 Quarter
Balance	`StockholdersEquity`	$5.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$-8.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.